A citation-based method for searching scientific literature

E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
Times Cited: 260







List of co-cited articles
596 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Primary care physicians' knowledge of and experience with pharmacogenetic testing.
S B Haga, W Burke, G S Ginsburg, R Mills, R Agans. Clin Genet 2012
154
42


Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
248
24

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
346
23

Assessment of the pharmacogenomics educational needs of pharmacists.
Kristen B McCullough, Christine M Formea, Kevin D Berg, Julianna A Burzynski, Julie L Cunningham, Narith N Ou, Maria I Rudis, Joanna L Stollings, Wayne T Nicholson. Am J Pharm Educ 2011
112
19

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
123
19

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin Pharmacol Ther 2011
571
18

Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.
Katherine A Johansen Taber, Barry D Dickinson. Pharmgenomics Pers Med 2014
73
23

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
863
15

Attitudes of clinicians following large-scale pharmacogenomics implementation.
J F Peterson, J R Field, Y Shi, J S Schildcrout, J C Denny, T L McGregor, S L Van Driest, J M Pulley, I M Lubin, M Laposata,[...]. Pharmacogenomics J 2016
46
30


Educational strategies to enable expansion of pharmacogenomics-based care.
Kristin Wiisanen Weitzel, Christina L Aquilante, Samuel Johnson, David F Kisor, Philip E Empey. Am J Health Syst Pharm 2016
47
27


PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
146
12

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
P C D Bank, K E Caudle, J J Swen, R S Gammal, M Whirl-Carrillo, T E Klein, M V Relling, H-J Guchelaar. Clin Pharmacol Ther 2018
95
12

An evaluation of pharmacists' expectations towards pharmacogenomics.
Simon de Denus, Nathalie Letarte, Thierry Hurlimann, Jean-Philippe Lambert, Annie Lavoie, Laura Robb, Nancy L Sheehan, Jacques Turgeon, Barbara Vadnais. Pharmacogenomics 2013
51
23

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
389
11

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, Richard M Weinshilboum, Liewei Wang, Kelly J Lyke, Euijung Ryu, Paul V Targonski, Michael D Van Norstrand, Matthew A Hathcock,[...]. Mayo Clin Proc 2014
177
11

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
198
11

Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States.
John E Murphy, James S Green, Laura A Adams, Robert B Squire, Grace M Kuo, Alan McKay. Am J Pharm Educ 2010
85
12


Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
M Verbelen, M E Weale, C M Lewis. Pharmacogenomics J 2017
88
12


Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
162
10

Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing.
Sony Tuteja, Kevin Haynes, Cara Zayac, Jon E Sprague, Barbara Bernhardt, Reed Pyeritz. Per Med 2013
40
25

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
43
23

Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine.
James S Green, Travis J O'Brien, Vincent A Chiappinelli, Arthur F Harralson. Pharmacogenomics 2010
50
20

Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.
Christina G Selkirk, Scott M Weissman, Andy Anderson, Peter J Hulick. Genet Test Mol Biomarkers 2013
79
12

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
72
13

Development and use of active clinical decision support for preemptive pharmacogenomics.
Gillian C Bell, Kristine R Crews, Mark R Wilkinson, Cyrine E Haidar, J Kevin Hicks, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Shane J Cross, Scott C Howard,[...]. J Am Med Inform Assoc 2014
123
9

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
260
9

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
327
9

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
L J Rasmussen-Torvik, S C Stallings, A S Gordon, B Almoguera, M A Basford, S J Bielinski, A Brautbar, M H Brilliant, D S Carrell, J J Connolly,[...]. Clin Pharmacol Ther 2014
141
9

Attitudes and practices among internists concerning genetic testing.
Robert Klitzman, Wendy Chung, Karen Marder, Anita Shanmugham, Lisa J Chin, Meredith Stark, Cheng-Shiun Leu, Paul S Appelbaum. J Genet Couns 2013
104
9

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
199
9

Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Aniwaa Owusu-Obeng, Kristin W Weitzel, Randy C Hatton, Benjamin J Staley, Jennifer Ashton, Rhonda M Cooper-Dehoff, Julie A Johnson. Pharmacotherapy 2014
77
11

HLA-B*5701 screening for hypersensitivity to abacavir.
Simon Mallal, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores Cid,[...]. N Engl J Med 2008
9

Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
Simona Volpi, Carol J Bult, Rex L Chisholm, Patricia A Deverka, Geoffrey S Ginsburg, Howard J Jacob, Melpomeni Kasapi, Howard L McLeod, Dan M Roden, Marc S Williams,[...]. Clin Pharmacol Ther 2018
54
16

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
95
9

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
R P McKillip, B A Borden, P Galecki, S A Ham, L Patrick-Miller, J P Hall, S Hussain, K Danahey, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
15
53

Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Lucas M Walden, Eva J Brandl, Amtul Changasi, Jessica E Sturgess, Alexander Soibel, Janna Fe D Notario, Sheraz Cheema, Nicole Braganza, Victoria S Marshe, Natalie Freeman,[...]. Psychiatry Res 2015
26
30

Pharmacogenetics: from bench to byte.
J J Swen, I Wilting, A L de Goede, L Grandia, H Mulder, D J Touw, A de Boer, J M H Conemans, T C G Egberts, O H Klungel,[...]. Clin Pharmacol Ther 2008
142
8

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
226
8

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
533
8

Comparison of delivery strategies for pharmacogenetic testing services.
Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
30
26

Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.
Kim M Unertl, Habiba Jaffa, Julie R Field, Lisa Price, Josh F Peterson. Per Med 2015
37
21

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.
Kathrin Blagec, Rudolf Koopmann, Mandy Crommentuijn-van Rhenen, Inge Holsappel, Cathelijne H van der Wouden, Lidija Konta, Hong Xu, Daniela Steinberger, Enrico Just, Jesse J Swen,[...]. J Am Med Inform Assoc 2018
27
29

Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Amy A Lemke, Christina G Hutten Selkirk, Nicole S Glaser, Annette W Sereika, Dyson T Wake, Peter J Hulick, Henry M Dunnenberger. Per Med 2017
23
34

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
49
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.